GSK’s share price has risen a lot this year, boosted by its strong Q3 results, but huge value could remain, based on its ...

Wondering if GSK is actually undervalued or if there's more to the story than recent headlines suggest? You're not alone, and we're about to dive into what those numbers really mean. Despite a slight ...

GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK has announced the purchase of 175,000 of its own ordinary shares as part of its ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline, with a price target of £16.00. The company’s shares opened today at p1,765.00. Take ...

Jefferies analyst Michael Leuchten reiterated a Buy rating on GlaxoSmithKline today and set a price target of p2,100.00. The company’s shares closed today at p1,757.00. Take advantage of TipRanks ...

GSK’s fair value estimate has seen a modest increase, rising from $16.63 to $17.36 per share. The discount rate remains ...

Emma Walmsley will step down as chief executive of GSK (GSK) at the end of this year, but she will be going out on a high ...

GSK Pharma share price fell 3 per cent after it reported a lower-than-expected top-line for the second quarter of the current ...

Next set to turn heads with special dividend, upbeat Q3 numbers from GSK bolster FY outlook,, WH Smith FY numbers to follow ...

India's GlaxoSmithKline Pharmaceuticals reported slightly higher second-quarter profit on Thursday, led by steady demand for ...